BioWorld

March 28, 2016

View Archived Issues

Week in review

Read More

Word on the street

Read More

Week in Washington

Read More

Top 10 biopharmaceutical M&As in 2016

Read More

Human Vaccines Project looks to decode the immune system

Last week, Pfizer Inc. was the latest drug company to sign on to the Human Vaccines Project, a nonprofit public-private partnership with the lofty goal of decoding the immune system to make vaccine development more effective. Read More

Completed biopharmaceutical mergers and acquisitions: January 1 - March 24, 2016

Read More

Pending biopharmaceutical mergers and acquisitions

Read More

The week's biggest gainers and losers

Read More

BioWorld stock report for public biotechnology companies

Read More

Money raised by biotech in 2016 vs. 2015

Read More

Money raised by biotech: Jan. 1 - March 17, 2016

Read More